Page:ICD-10-CM (2010).djvu/1648

and antimuscarinics] and spasmolytics

T44.3x1 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional)

Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics NOS

T44.3x2 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm

T44.3x3 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault

T44.3x4 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined

T44.3x5 Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics

T44.3x6 Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics

T44.4 Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists

Poisoning by, adverse effect of and underdosing of metaraminol

T44.4x Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists

T44.4x1 Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional)

Poisoning by predominantly alpha-adrenoreceptor agonists NOS

T44.4x2 Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm

T44.4x3 Poisoning by predominantly alpha-adrenoreceptor agonists, assault

T44.4x4 Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined

T44.4x5 Adverse effect of predominantly alpha-adrenoreceptor agonists

T44.4x6 Underdosing of predominantly alpha-adrenoreceptor agonists

T44.